These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4595329)

  • 1. Immunoprophylaxis and treatment of leukemia in AKR mice: repetitive use of BCG.
    Mardiney MR; Ungaro PC; Drake WP
    Natl Cancer Inst Monogr; 1973 Dec; 39():89-90. PubMed ID: 4595329
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.
    Lemonde P
    Natl Cancer Inst Monogr; 1973 Dec; 39():21-32. PubMed ID: 4362522
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of B.C.G. on the hepatic catalase activity in mouse. Relation between the reticuloendothelial system and the resistance against grafted AKR leukemia].
    Lamensans A; Mollier MF; Laurent M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):871-6. PubMed ID: 4885127
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 7. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oncological characteristics of AKR/JY mice].
    Khar'kovskaia NA; Khrustalev SA
    Eksp Onkol; 1984; 6(4):62-6. PubMed ID: 6548693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid.
    Drake WP; Cimino EF; Mardiney MR; Sutherland JC
    J Natl Cancer Inst; 1974 Mar; 52(3):941-4. PubMed ID: 4596992
    [No Abstract]   [Full Text] [Related]  

  • 10. Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice.
    Ungaro PC; Drake WP; Mardiney MR
    J Natl Cancer Inst; 1973 Jan; 50(1):125-8. PubMed ID: 4692859
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 12. [The course of tuberculous inflammaton in guinea pigs, vaccinated with BCG, under the effect of hypersensitization].
    Diaconiţă G
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):249-63. PubMed ID: 4936240
    [No Abstract]   [Full Text] [Related]  

  • 13. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.
    Tree JA; Williams A; Clark S; Hall G; Marsh PD; Ivanyi J
    Clin Exp Immunol; 2004 Dec; 138(3):405-9. PubMed ID: 15544615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulating influence of bacillus Calmette-Guérin on immunity to polyoma tumors and spontaneous leukemia.
    Lemonde P; Dubreuil R; Guindon A; Lussier G
    J Natl Cancer Inst; 1971 Nov; 47(5):1013-24. PubMed ID: 4330795
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of drug therapy against a histologically defined rat leukemia.
    Pearson JW; Chaparas SD; Torgersen JA; Perk K; Chirigos MA; Sher NA
    Cancer Res; 1974 Feb; 34(2):355-61. PubMed ID: 4589956
    [No Abstract]   [Full Text] [Related]  

  • 19. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG and the lympho-reticuloendothelial system.
    Rosenthal SR
    Natl Cancer Inst Monogr; 1973 Dec; 39():91-106. PubMed ID: 4595330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.